New shot tested for Tough-to-Treat seasonal allergies
NCT ID NCT07091357
Summary
This study is testing an investigational injection called SHR-1819 for adults with seasonal allergic rhinitis (hay fever) who haven't gotten enough relief from standard allergy medications like nasal sprays or antihistamines. About 100 participants will receive either the injection or a placebo to compare how well it reduces nasal symptoms and how safe it is. The goal is to see if this new treatment can better control allergy symptoms during pollen season.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.